Search research articles
Contact Us
Filters
Showing results (121-130 of 167) with videos related to
Page
of 17
Sort By:
International Journal of Cancer
|
June 5, 2019
Lung cancer mortality reduction by LDCT screening-Results from the randomized German LUSI trial
Nikolaus Becker, Erna Motsch, Anke Trotter, et al.
Acta Radiologica (Stockholm, Sweden : 1987)
|
April 19, 2011
Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and diffusion-weighted imaging of bone marrow in healthy individuals
Jens Hillengass, Bram Stieltjes, Tobias Bäuerle, et al.
Radiology
|
August 26, 2009
Multiple myeloma and monoclonal gammopathy of undetermined significance: importance of whole-body versus spinal MR imaging
Tobias Bäuerle, Jens Hillengass, Kerstin Fechtner, et al.
Neoplasia (New York, N.Y.)
|
May 22, 2004
Dynamic contrast-enhanced magnetic resonance imaging rapidly indicates vessel regression in human squamous cell carcinomas grown in nude mice caused by VEGF receptor 2 blockade with DC101
Fabian Kiessling, Nabeel Farhan, Matthias P Lichy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 16, 2009
Dynamic contrast-enhanced magnetic resonance imaging identifies a subgroup of patients with asymptomatic monoclonal plasma cell disease and pathologic microcirculation
Jens Hillengass, Christian Zechmann, Tobias Bäuerle, et al.
European Radiology
|
September 9, 2017
Effect of smoking cessation on quantitative computed tomography in smokers at risk in a lung cancer screening population
Bertram J Jobst, Oliver Weinheimer, Mila Trauth, et al.
BMC Cancer
|
March 24, 2012
A phase II study for metabolic in vivo response monitoring with sequential 18FDG-PET-CT during treatment with the EGFR-monoclonal-antibody cetuximab in metastatic colorectal cancer: the Heidelberg REMOTUX trial
Anne Katrin Berger, Carl von Gall, Ulrich Abel, et al.
Plos One
|
March 15, 2014
Validation of anthropometric indices of adiposity against whole-body magnetic resonance imaging--a study within the German European Prospective Investigation into Cancer and Nutrition (EPIC) cohorts
Jasmine Neamat-Allah, Diana Wald, Anika Hüsing, et al.
British Journal of Haematology
|
May 24, 2022
Whole-body magnetic resonance imaging plus serological follow-up for early identification of progression in smouldering myeloma patients to prevent development of end-organ damage
Markus Wennmann, Hartmut Goldschmidt, Jennifer Mosebach, et al.
Investigative Radiology
|
April 17, 2004
Assessment of irradiated brain metastases by means of arterial spin-labeling and dynamic susceptibility-weighted contrast-enhanced perfusion MRI: initial results
Marc-André Weber, Christoph Thilmann, Matthias P Lichy, et al.
Page
of 17
Search research articles
Search
Showing results (121-130 of 167) with videos related to
Sort By:
Page
of 17
International Journal of Cancer
|
June 5, 2019
Lung cancer mortality reduction by LDCT screening-Results from the randomized German LUSI trial
Nikolaus Becker, Erna Motsch, Anke Trotter, et al.
Acta Radiologica (Stockholm, Sweden : 1987)
|
April 19, 2011
Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and diffusion-weighted imaging of bone marrow in healthy individuals
Jens Hillengass, Bram Stieltjes, Tobias Bäuerle, et al.
Radiology
|
August 26, 2009
Multiple myeloma and monoclonal gammopathy of undetermined significance: importance of whole-body versus spinal MR imaging
Tobias Bäuerle, Jens Hillengass, Kerstin Fechtner, et al.
Neoplasia (New York, N.Y.)
|
May 22, 2004
Dynamic contrast-enhanced magnetic resonance imaging rapidly indicates vessel regression in human squamous cell carcinomas grown in nude mice caused by VEGF receptor 2 blockade with DC101
Fabian Kiessling, Nabeel Farhan, Matthias P Lichy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 16, 2009
Dynamic contrast-enhanced magnetic resonance imaging identifies a subgroup of patients with asymptomatic monoclonal plasma cell disease and pathologic microcirculation
Jens Hillengass, Christian Zechmann, Tobias Bäuerle, et al.
European Radiology
|
September 9, 2017
Effect of smoking cessation on quantitative computed tomography in smokers at risk in a lung cancer screening population
Bertram J Jobst, Oliver Weinheimer, Mila Trauth, et al.
BMC Cancer
|
March 24, 2012
A phase II study for metabolic in vivo response monitoring with sequential 18FDG-PET-CT during treatment with the EGFR-monoclonal-antibody cetuximab in metastatic colorectal cancer: the Heidelberg REMOTUX trial
Anne Katrin Berger, Carl von Gall, Ulrich Abel, et al.
Plos One
|
March 15, 2014
Validation of anthropometric indices of adiposity against whole-body magnetic resonance imaging--a study within the German European Prospective Investigation into Cancer and Nutrition (EPIC) cohorts
Jasmine Neamat-Allah, Diana Wald, Anika Hüsing, et al.
British Journal of Haematology
|
May 24, 2022
Whole-body magnetic resonance imaging plus serological follow-up for early identification of progression in smouldering myeloma patients to prevent development of end-organ damage
Markus Wennmann, Hartmut Goldschmidt, Jennifer Mosebach, et al.
Investigative Radiology
|
April 17, 2004
Assessment of irradiated brain metastases by means of arterial spin-labeling and dynamic susceptibility-weighted contrast-enhanced perfusion MRI: initial results
Marc-André Weber, Christoph Thilmann, Matthias P Lichy, et al.
Page
of 17